You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Cefadroxil/cefadroxil hemihydrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cefadroxil/cefadroxil hemihydrate and what is the scope of freedom to operate?

Cefadroxil/cefadroxil hemihydrate is the generic ingredient in three branded drugs marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Warner Chilcott, Bristol, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

Twenty-two suppliers are listed for this compound.

Summary for cefadroxil/cefadroxil hemihydrate
Pharmacology for cefadroxil/cefadroxil hemihydrate
Anatomical Therapeutic Chemical (ATC) Classes for cefadroxil/cefadroxil hemihydrate

US Patents and Regulatory Information for cefadroxil/cefadroxil hemihydrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva CEFADROXIL cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 062695-001 Feb 10, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms CEFADROXIL cefadroxil/cefadroxil hemihydrate TABLET;ORAL 062774-001 Apr 8, 1987 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ranbaxy CEFADROXIL cefadroxil/cefadroxil hemihydrate TABLET;ORAL 065018-001 Apr 23, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz CEFADROXIL cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 062291-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.